Actively Recruiting
Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET
Led by The University of Hong Kong · Updated on 2025-06-12
716
Participants Needed
1
Research Sites
282 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomised double-blinded controlled trial aims to compare the live birth rate in natural FET cycles with and without oral dydrogesterone as luteal phase support. The hypothesis is that the use of oral dydrogesterone will increase the live birth rate of natural cycle FET.
CONDITIONS
Official Title
Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged less than 43 years at the time of stimulated IVF
- Undergoing replacement of early cleavage embryos or blastocysts after thawing
You will not qualify if you...
- Requiring hormonal replacement cycles
- Use of donor oocytes or embryos
- Undergoing preimplantation genetic testing
- Presence of hydrosalpinx not surgically corrected before frozen embryo transfer
- Refusing to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China
Actively Recruiting
Research Team
E
Ernest HY Ng, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here